ClinConnect ClinConnect Logo
Search / Trial NCT02960737

Dysphagia Evaluation After Stroke- Effect Oral Neuromuscular Training on Swallowing Dysfunction

Launched by UMEÅ UNIVERSITY · Nov 7, 2016

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

Dysphagia Stroke Intervention Oral Neuromuscular Training Randomized Control Trial

ClinConnect Summary

This clinical trial is looking at how a special rehabilitation program, which uses an oral device, can help improve swallowing difficulties (called dysphagia) in people who have had a stroke. Many stroke patients struggle with swallowing long after their stroke, and this study aims to see if this specific training can make a difference for them.

To participate in the trial, patients need to be between 65 and 74 years old and must still have swallowing issues at least 12 weeks after their first stroke. However, those with other serious health problems that affect swallowing or their ability to participate won't be included. If eligible, participants can expect to engage in targeted exercises using the oral device to help strengthen their swallowing muscles. The study is currently recruiting, and it's a chance to contribute to research that could improve recovery for many stroke survivors facing swallowing challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Persistent dysphagia 12(±3) weeks after STROKE.
  • Exclusion Criteria:
  • Stroke patients with neurologic or psychiatric disorders or other diseases/conditions that can affect swallowing function.
  • Unable to collaborate due to other serious diseases and/or to affected general condition.

About Umeå University

Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.

Locations

Umeå, , Sweden

Patients applied

0 patients applied

Trial Officials

Patricia Hägglund, PhD/SLP

Principal Investigator

Umeå University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials